Parkland Health Foundation is grateful to announce a $500,000 philanthropic investment from the McKesson Foundation to support colorectal cancer care for Parkland patients.
This funding will help provide Parkland patients with a less-invasive, quicker alternative to a colonoscopy known as flexible sigmoidoscopy.
“Flexible sigmoidoscopy is an essential tool in the screening, assessment and treatment of patients with colorectal cancer,” said Umber Dickerson, Administrative Director of Global Cancer Programs at Parkland Health. “With this new technology, we can provide the best possible care to our patients and ensure their continued comfort and quality of life.”
According to the 2022 Dallas County Community Health Needs Assessment, cancer is the second leading cause of death in Dallas County. Nationwide, colorectal cancer is the second most common cause of cancer deaths overall. According to the American Cancer Society, colorectal cancer also disproportionately affects the Black community, where the rates are the highest of any racial/ethnic group in the US. Black Americans are about 20% more likely to get colorectal cancer and about 40% more likely to die from it than most other groups.
The McKesson Foundation’s philanthropic investment is a continuation of its commitment to remove socioeconomic barriers to quality healthcare for vulnerable and underserved communities. In 2022, the McKesson Foundation awarded a $500,000 grant to Parkland’s C.V. Roman Health Center in the RedBird Dallas neighborhood, expanding access to care to residents residing in southern Dallas County.
“As the McKesson Foundation celebrates 80 years of impact this year, we are building upon our focus and dedication to advancing health outcomes for all,” said Nimesh Jhaveri, RPh, a director of the McKesson Foundation. “We are excited to continue our partnership with Parkland Health and the Parkland Health Foundation as we address barriers in Dallas County and help reduce the burden of cancer in our community.”
“Parkland Health Foundation is grateful for the McKesson Foundation’s partnership to respond to our community’s urgent needs,” said Michael Horne, EdD, MPP, president and CEO, Parkland Health Foundation. “It’s amazing to have such a strong partner helping provide a more efficient way to detect colon cancer and ultimately, save lives.”
About the McKesson Foundation
Founded in 1943, the McKesson Foundation is a 501(c)(3) corporate foundation dedicated to advancing health outcomes for all. It is affiliated with Irving, Texas-based McKesson Corporation, a diversified healthcare services provider. The Foundation’s mission is to remove barriers to quality healthcare across North America, especially for vulnerable and underserved communities. The Foundation works to achieve its mission through partnerships and charitable grants in three core areas: reducing the burden of cancer, preparing tomorrow’s healthcare workforce, and accelerating crisis response. The Foundation further amplifies its impact in the communities where Team McKesson lives, works and operates by promoting employee volunteerism and bolstering charitable giving. For more information about the McKesson Foundation, click here.
About Parkland Health Foundation
Parkland Health Foundation is a 501(c)(3) dedicated to securing substantial financial resources that advance the goals of Parkland Health (Parkland). Parkland’s mission is to advance wellness, relieve suffering, develop and educate. Our vision is to advance health equity through excellence as a public health system. Parkland Health Foundation is dedicated to ensuring that our community has a medical home for a continuum of care from birth to end of life.